Format

Send to

Choose Destination
See comment in PubMed Commons below
J Invest Dermatol. 2012 Oct;132(10):2422-2429. doi: 10.1038/jid.2012.166. Epub 2012 May 24.

TGM5 mutations impact epidermal differentiation in acral peeling skin syndrome.

Author information

1
Department of Dermatology, University Freiburg Medical Center, Freiburg, Germany.
2
Service of Dermatology, University Hospital Nuestra Señora de Candelaria Carretera del Rosario, Santa Cruz de Tenerife, Spain.
3
Institute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.
4
Department of Pathology, Turku University Hospital, Turku, Finland.
5
Department of Dermatology, Turku University Hospital, Turku, Finland.
6
Department of Dermatology, University Freiburg Medical Center, Freiburg, Germany; Freiburg Institute for Advanced Studies, School of Life Sciences-LifeNet, University of Freiburg, Freiburg, Germany.
7
Department of Dermatology, University Freiburg Medical Center, Freiburg, Germany. Electronic address: cristina.has@uniklinik-freiburg.de.

Abstract

Acral peeling skin syndrome (APSS) is an autosomal recessive skin disorder characterized by acral blistering and peeling of the outermost layers of the epidermis. It is caused by mutations in the gene for transglutaminase 5, TGM5. Here, we report on clinical and molecular findings in 11 patients and extend the TGM5 mutation database by four, to our knowledge, previously unreported mutations: p.M1T, p.L41P, p.L214CfsX15, and p.S604IfsX9. The recurrent mutation p.G113C was found in 9 patients, but also in 3 of 100 control individuals in a heterozygous state, indicating that APSS might be more widespread than hitherto expected. Using quantitative real-time PCR, immunoblotting, and immunofluorescence analysis, we demonstrate that expression and distribution of several epidermal differentiation markers and corneodesmosin (CDSN) is altered in APSS keratinocytes and skin. Although the expression of transglutaminases 1 and 3 was not changed, we found an upregulation of keratin 1, keratin 10, involucrin, loricrin, and CDSN, probably as compensatory mechanisms for stabilization of the epidermal barrier. Our results give insights into the consequences of TGM5 mutations on terminal epidermal differentiation.

PMID:
22622422
DOI:
10.1038/jid.2012.166
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center